Tuesday, Jul 8, 2025 · SEC filings

What the smart money revealed on Jul 8

Real insider buys7insiders · $514K
Real insider sales22insiders · $16.4M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

244 insider filings came in. We hid 61 planned (10b5-1) sellers and 140 people whose filings were routine, like grants and tax withholding.

trending_up

Calamos Aksia Private Equity & Alternatives Fund Vice President and CFO Thomas Herman bought $450K

44,995 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jul 7
$450K
trending_up

Columbia Credit Income Opportunities Fund Officer Gene Tannuzzo bought $54K

2,650 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jun 25
$54K
trending_down

Core & Main (CNM) Executive Chair Stephen LeClair sold $7.77M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 70,736 shares directly.

Real sale Form 4 Traded Jul 3–7
$7.77M
trending_down

Thumzup Media (TZUP) CEO Robert Steele sold $2.5M

Not marked as a planned 10b5-1 sale. Sold 81% of the shares they held directly. Still holds 1.21M shares.

Real sale Form 4 Sold 81% of stake Traded Jul 7
$2.5M
trending_down

Oracle (ORCL) EVP Maria Smith sold $2.33M

Not marked as a planned 10b5-1 sale. Sold 20% of the shares they held directly. Still holds 40,807 shares.

Real sale Form 4 Traded Jul 3
$2.33M
Show 5 more real buys
Show 19 more real sales
INTU Intuit · EVP and CFO Sandeep Aujla · Traded Jul 3
$2.03M
FDX FedEx · Director Paul Walsh · Traded Jul 8
$860K
TDW Tidewater · EVP & General Counsel Daniel Hudson · Traded Jul 8
$250K
HQY HealthEquity · EVP Michael Fiore · Traded Jul 7
$183K
BPMC Blueprint Medicines · COO Christina Rossi · Traded Jul 3
$150K
TRAK ReposiTrak · CEO Randall Fields · Traded Jul 7–8
$147K
BPMC Blueprint Medicines · Chief Scientific Officer Percy Carter · Traded Jul 3
$135K
MYPS Playstudios · General Counsel Joel Agena · Traded Jul 3–7
$51.4K
IAS Integral Ad Science Holding · Chief Accounting Officer Alexis Gil II · Traded Jul 7
$16.5K
ZSPC zSpace · CEO Paul Kellenberger · Traded Jul 3–7
$8.07K
GEVO Gevo · EVP L. Lynn Smull · Traded Jul 1
$5.23K
RCKT Rocket Pharmaceuticals · CFO Aaron Ondrey · Traded Jul 3
$4.25K
FTHM Fathom · Chief Broker Officer Samantha Giuggio · Traded Jul 3
$2.96K
GLTO Galecto · CEO Hans Schambye · Traded Jul 3
$2.48K
ALXO Alx Oncology · SVP Shelly Pinto · Traded Jul 7
$905
GLTO Galecto · General Counsel Garrett Winslow · Traded Jul 3
$881
CZFS Citizens Financial Services · Executive Vice President LeeAnn Gephart · Traded Jul 8
$835
SERA Sera Prognostics · Director Mansoor Mirza · Traded Jul 7
$552
GLTO Galecto · Interim CFO Lori Firmani · Traded Jul 3
$498

13F season

Holdings as of Jun 30, 2025 are due Aug 14

97 funds have filed so far. 92 filed for the quarter before.

Biggest real insider buys, Jul 2–8

Open-market buys by officers and directors, filed in the 7 days up to Jul 8.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist